CB Therapeutics Expands Synthetic Biology Platform to Produce Valuable Diterpenoids from Salvia

Retrieved on: 2025-02-10 20:21:43

Tags for this article:

Click the tags to see associated articles and topics

CB Therapeutics Expands Synthetic Biology Platform to Produce Valuable Diterpenoids from Salvia. View article details on hiswai:

Excerpt

CARLSBAD, CA, UNITED STATES, February 10, 2025 /EINPresswire.com/ -- CB Therapeutics, a U.S.-based synthetic biology company specializing in the ...

Article found on: kalkinemedia.com